Epidemiological studies on primipaternity and immunology in preeclampsia - a statement after twelve years of workshops

Journal of Reproductive Immunology

Volumn 89, Issue 2, 2011, Pages 104-117

  Robillard, Pierre Yves ^a   Dekker, Gustaaf ^b   Chaouat, Gérard ^c   Hulsey, Thomas C ^d   Saftlas, Audrey ^e  

^a Neonatology   (France)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c INSERM   (France)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Epidemiology; Immunology; Preeclampsia; Primipaternity

Indexed keywords

CELL ACTIVATION; CELL INVASION; CONTRACEPTION; ENDOTHELIUM CELL; HUMAN; IMMUNOLOGY; MATERNAL HYPERTENSION; NATURAL KILLER CELL; PATERNITY; PREECLAMPSIA; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEINURIA; REGULATORY T LYMPHOCYTE; REVIEW; SEMINAL PLASMA; TROPHOBLAST;

ANIMALS; ANNIVERSARIES AND SPECIAL EVENTS; EDUCATION; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PARITY; PRE-ECLAMPSIA; PREGNANCY;

EID: 79956146185     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.02.003     Document Type: Review

References (54)

1. Beer A.E. Immunology, contraception and preeclampsia. J. Am. Med. Ass. 1989, 262:3184.
2. Chaouat G., Ledee-Bataille N., Dubanchet S. Immunological similarities between implantation and pre-eclampsia. Am. J. Reprod. Immunol. 2005, 53(5):222-229.
3. Chesley T.C. Epidemiology of preeclampsia-eclampsia. Hypertensive Disorders of Pregnancy 1978, p.35-55. Appleton-Century-Crofts, New York. T.C. Chesley (Ed.).
4. Cole L.A., Khanlian S.A., Kohorn E.I. Evolution of the human brain, chorionic gonadotrophin and hemochorial implantation of the placenta: insights into origins of pregnancy failures, preeclampsia and choriocarcinoma. J. Reprod. Med. 2008, 53(8):549-557.
5. Croy B.A., Ashkar A.A., Minhas K., Greenwood J.D. Can murine uterine natural killer cells give insights into the pathogenesis of preeclampsia?. J. Soc. Gynecol. Investig. 2001, 7:12-20.
6. Davies A.M. Epidemiology of pregnancy toxemias. Geographical Epidemiology of the Toxemias of Pregnancy 1971, 8-75. Thomas C.C, Springfield. A.M. Davies (Ed.).
7. Dekker G.A., Robillard P.Y. Immune maladaptation in the aetiology of preeclampsia; an updated epidemiological perspective. Pre-eclampsia. Aetiology and Clinical Practice 2007, 276-294. Cambridge University Press, Cambridge. F. Lyall, M. Belfort (Eds.).
8. Dekker G.A., Robillard P.Y. Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update. J. Reprod. Immunol. 2007, 76(1-2):8-16.
9. Dieckmann W.J. Incidence of eclampsia and other toxemias of pregnancy. The Toxemias of Pregnancy 1952, 33-57. CV Mosby, St. Louis. W.J. Dieckmann (Ed.).
10. Einarsson J.I., Sangi-Haghpeykar H., Gardner M.O. Sperm exposure and development of preeclampsia. Am. J. Obstet. Gynecol. 2003, 188(5):1241-1243.
11. Girardi G., Yarilin D., Thurmann J.M., Holers V.M., Salmon J.E. Complement activation induces dysregulation of angiogenic factors and causes foetal rejection and growth restriction. J. Exp. Med. 2006, 9(203):2165-2175.
12. Gratacos E., Torres P.J., Cararach V., Quinto L., Alonso P.L., Fortuny A. Does the use of contraception reduce the risk of pregnancy-induced hypertension?. Hum. Reprod. 1996, 11(10):2138-2141.
13. Haig D. Genetic conflicts in human pregnancy. Q. Rev. Biol. 1993, 68:495-532.
14. Hiby S.E., Walker J.J., O'Shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., Moffett A. Combinations of maternal KIR and foetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 2004, 200(8):957-965.
15. Ikedife D. Eclampsia in multiparae. Br. Med. J. 1980, 280:985-986.
16. Kalkunte S., Boij R., Norris W., Friedman J., Lai Z., Kurtis J., Lim K.H., Padbury J.F., Matthiesen L., Sharma S. Sera from preeclamptic patients elicit symptoms of human disease in mice and provide a basis for an in-vitro predictive assay. Am. J. Pathol. 2010, 177(5):2387-2398.
17. Kho E.M., McCowan L.M., North R.A., Roberts C.T., Chan E., Black M.A., Taylor R.S., Dekker G.A. SCOPE consortium duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. Reprod. Immunol. 2009, 82(1):66-73.
18. Klonoff-Cohen H.S., Savitz D.A., Cefalo R.C., McCann M.F. An epidemiologic study of contraception and preeclampsia. J. Am. Med. Ass. 1989, 262:3143-3147.
19. Koopman L.A., Kopcow H.D., Rybalov B., Boyson J.E., Orange J.S., Schatz F., Masch R., Lockwood C.J., Schachter A.D., Park P.J., Strominger J.L. Human decidual natural killer cells are a unique Nkcell subset with immunomodulatory potential. J. Exp. Med. 2003, 198(8):1201-1212.
20. Kosmak G.W. Toxemias of pregnancy. Toxemias of Pregnancy 1931, 12-62. D. Appleton Century Co., New York. 2nd ed. G.W. Kosmak (Ed.).
21. Le Bouteiller P., Fons P., Herault J.P., Bono F., Chabot S., Cartwright J.E., Bensussan A. Soluble HLA-G and control of angiogenesis. J. Reprod. Immunol. 2007, 76:17-22.
22. Loke Y.W., King A. Recent developments in the human maternal-fetal immune interaction. Curr. Opin. Immunol. 1991, 5:762-766.
23. MacGillivray I. Epidemiology of pre-eclampsia and eclampsia. Preeclampsia 1983, 8-22. W.B. Saunders, London. I. MacGillivray (Ed.).
24. Marti J.J., Herrman U. Immunogestosis: a new etiologic concept of " essential" EPH gestosis, with special consideration of the primigravid patient. Am. J. Obstet. Gynecol. 1977, 128:489-493.
25. Martin R.D. Scaling of the mammalian brain: the maternal-energy hypothesis. News. Physiol. Sci. 1996, 11:149-156.
26. Medawar P.B. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol. 1953, 7:320-338.
27. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002, 2:656-663.
28. Moffett A., Hiby S.E. Immunological factors and placentation: implications for pre-eclampsia. Pre-eclampsia. Aetiology and Clinical Practice 2007, 92-102. Cambridge University Press, Cambridge. F. Lyall, M. Belfort (Eds.).
29. Morcos R.N., Bourguet C.C., Gill P.P., Khawil O., Krew M.A., Eucker J., Skarote P. Pregnancy-induced hypertension and duration of sexual cohabitation. J. Reprod. Med. 2000, 45(3):207-212.
30. Ness R.B., Markovic N., Harger G., Day R. Barrier methods, length of preconception intercourse, and preeclampsia. Hypertens. Preg. 2004, 23(3):227-235.
31. Olayeni O., Strobino D., Aimakhu C., Adepako K., Kehinde A., Odukogbe A.T., Saleko B. Influence of duration of sexual cohabitation on the risk of hypertension in nulliparous parturients in Ibadan: a cohort study. Aust. N.Z. Obstet. Gynaecol. 2010, 50:40-44.
32. Paine M.A., Scioscia M., Williams P.J., Gumma K., Rodeck C.H., Rademacher T.W. Urinary inositol phosphoglycans P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder. Hypertens. Preg. 2010, 29(4):375-384.
33. Parham P. NK cells and trophoblasts: partners in pregnancy. J. Exp. Med. 2004, 200(8):951-955.
34. Pijnenborg R. The placental bed. Hypertens. Preg. 1996, 15:7-23.
35. Redecha P., van Rooijen N., Torry D., Girardi G. Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 2009, 113(17):4101-4109. 23.
36. Redman C.W.G., Sargent I.L. Immunological factors and placentation: implications for pre-eclampsia. Pre-eclampsia. Aetiology and Clinical Practice 2007, 103-120. Cambridge University Press, Cambridge. F. Lyall, M. Belfort (Eds.).
37. Redman C.W.G., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010, 63:534-543.
38. Robertson S.A., Seamark E.F. Granulocyte macrophage colony stimulating factor (GM-CSF) in the murine reproductive tract: stimulation by seminal factors. Reprod. Fertil. Dev. 1990, 2:359-368.
39. Robertson S.A., Bromfield J.J., Tremellen K.P. Seminal priming for protection from pre-eclampsia - a unifying hypothesis. J. Reprod. Immunol. 2003, 59(2):253-265.
40. Robertson S.A., Guerin L.R., Moldenhauer L.M., Hayball J.D. Activating T regulatory cells for tolerance in early pregnancy - the contribution of seminal fluid. J. Reprod. Immunol. 2009, 83(1-2):109-116.
41. Robillard P.Y., Hulsey T.C., Périanin J., Janky E., Miri E.H., Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994, 344:973-975.
42. Robillard P.Y., Dekker G.A., Hulsey T.C. Revisiting the epidemiological standard of preeclampsia: primigravidity or primipaternity?. Eur. J. Obstet. Gynecol. Reprod. Biol. 1999, 84:37-41.
43. Robillard P.Y., Dekker G.A., Chouat G., Hulsey T.C. Etiology of preeclampsia: maternal vascular predisposition and couple disease - mutual exclusion or complementarity?. J. Reprod. Immunol. 2007, 76:1-7.
44. Saftlas A.F., Levine R.J., Klebanoff M.A., Martz K.L., Ewell M.G., Sibai B.M., Morris C.D. Abortion changed paternity, and risk of preeclampsia in nulliparous women. Am. J. Epidemiol. 2003, 157:1108-1114.
45. Saftlas A.F., Beydoun H., Triche E. Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstet. Gynecol. 2005, 106(1):162-172.
46. Saito S. Th17 cells and regulatory T cells. New light on pathophysiology of preeclampsia. Immunol. Cell. Biol. 2010, 88(6):615-617.
47. Saito S., Takeda Y., Sakai M., Nakabayahi M., Hayakawa S. The incidence of pre-eclampsia among couples consisting of Japanese women and Caucasian men. J. Reprod. Immunol. 2006, 71(2):132-133.
48. Saito S., Nakashima A., Shima T., Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 2010, 63(6):601-610.
49. Sela S., Itin A., Natanson-Yaron S., Greenfeld C., Goldman-Wohl D., Yagel S., Keshet E. A novel human-specific soluble vascular endothelial growth factor receptor 1. Cell type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ. Res. 2008, 102:1566-1574.
50. Silasi M., Cohen B., Karumanchi S.A., Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet. Gynecol. Clin. North. Am. 2010, 37(2):239-253.
51. Verwoerd G.R., Hall D.R., Grove D., Maritz J.S., Odendaal H.J. Primipaternity and duration of exposure to sperm antigens as risk factors for pre-eclampsia. Int. J. Obstet. Gynecol. 2002, 78:121-126.
52. Walker J.J. Pre-eclampsia. Lancet 2000, 356:1260-1265.
53. Wang J.X., Knottnerus A.M., Schuit G., Norman R.J., Chan A., Dekker G.A. Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. Lancet 2002, 359:673-674.
54. Williams P.J., Gumaa K., Scioscia M., Redman C.W., Rademacher T.W. Inositol phosphoglycan P-type in preeclampsia: a novel marker?. Hypertension 2007, 49:84-89.